HETEROCHROMIA IRIDIS

HETEROCHROMIA IRIDIS was reported 28 times

HETEROCHROMIA IRIDIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 12 0.0002
1 Carbonic Anhydrase Inhibitor [EPC] 3 0.0001
2 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
3 Prostaglandin Analog [EPC] 4 0.0000
4 Platinum-based Drug [EPC] 5 0.0000
5 Methylxanthine [EPC] 1 0.0000
6 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
7 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
8 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
9 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000